We are live on
!
Find out more
HP
Hosking Partners Portfolio holdings
AUM
$2.79B
1-Year Est. Return
58.33%
This Fund
S&P 500
This Quarter
Est. Return
+12.29%
1 Year Est. Return
+58.33%
3 Year Est. Return
+136.41%
5 Year Est. Return
+165.06%
10 Year Est. Return
+683.89%
AUM
$2.76B
AUM Growth
+$253M
(+10%)
Cap. Flow
+$3.14M
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
33.62%
Holding
121
New
3
Increased
33
Reduced
80
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$20.3M |
| 2 |
Nu Holdings
NU
|
+$8.58M |
| 3 |
LyondellBasell Industries
LYB
|
+$8.39M |
| 4 |
Quaker Houghton
KWR
|
+$7.48M |
| 5 |
Royalty Pharma
RPRX
|
+$6.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$9.79M |
| 2 |
PNC Financial Services
PNC
|
+$9.63M |
| 3 |
Millicom
TIGO
|
+$6.2M |
| 4 |
Wells Fargo
WFC
|
+$5.64M |
| 5 |
Peabody Energy
BTU
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.1% |
| 2 | Energy | 11.82% |
| 3 | Materials | 11.33% |
| 4 | Technology | 10.39% |
| 5 | Consumer Discretionary | 9.16% |
Similar funds
MC
AGA
HCC
SHIM
GI
SAM
AF
LGP
Hosking Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Hosking Partners held 121 positions worth $2.76B, up 10% from $2.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Hosking Partners's Q3 2025 filing shows 3 new, 33 increased, 80 reduced and 5 closed positions. Its largest new stake was Royalty Pharma: 170,604 shares worth $6.02M. The largest sale was Micron Technology, an estimated $9.79M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 35% a quarter earlier, followed by Energy and Materials.
- Hosking Partners's largest Q3 2025 buy was Royalty Pharma: 170,604 shares worth $6.02M.
- Hosking Partners added most to Elevance Health in Q3 2025, an estimated $20.3M increase.
- Hosking Partners's biggest Q3 2025 reduction was Micron Technology, cutting an estimated $9.79M.
- Hosking Partners fully exited Centene in Q3 2025, selling an estimated $3.64M.
- Hosking Partners's ten largest holdings make up 34% of its $2.76B portfolio in Q3 2025.
- Hosking Partners opened 3 new positions and closed 5 in Q3 2025.
- Hosking Partners's portfolio value rose 10% quarter-over-quarter to $2.76B.
Based on Hosking Partners's 13F filing for Q3 2025, filed 23 Oct 2025.